Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 19.814.86-11.939.9461.19

What is the latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS is 19.81 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202519.81
Mar20244.86
Mar2023-11.93
Mar20229.94
Mar202161.19

How is Core EBITDA Growth of EMCURE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 19.81
307.61
Mar2024 4.86
Positive
Mar2023 -11.93
Negative
Mar2022 9.94
-83.76
Mar2021 61.19 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹33,097.0 Cr 3.2% 3.2% 25.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,926.0 Cr -1.2% -2.3% 5.3% Stock Analytics
DIVIS LABORATORIES ₹175,062.0 Cr -1% -0.9% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,806.0 Cr -1.3% 1.4% 38.1% Stock Analytics
CIPLA ₹112,910.0 Cr -0.1% 4.8% -6.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,755.0 Cr -2.8% -0.3% 1.2% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

3.2%

3.2%

25.7%

SENSEX

-2%

-3.8%

-8.6%


You may also like the below Video Courses